{
  "id": 5439,
  "text": "Cancer Chemother Pharmacol 1986;18:280-283.Available at: http://www.ncbi.nlm.nih.gov/pubmed/3802384.258.Sutton GP, Blessing JA, McGuire WP, et al.Phase II trial of ifosfamide and mesna in patients with advanced or recurrent squamous carcinoma of the cervix who had never received chemotherapy: a Gynecologic Oncology Group study.",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: Cancer Chemother Pharmacol 1986;18:280-283.Available at: http://www.ncbi.nlm.nih.gov/pubmed/3802384.258.Sutton GP, Blessing JA, McGuire WP, et al.Phase II trial of ifosfamide and mesna in patients with advanced or recurrent squamous carcinoma of the cervix who had never received chemotherapy: a Gynecologic Oncology Group study.\n\n<question>: ",
  "ChatGPT_response_0": "根据相关研究，异环醚胺和美斯那化疗方案在宫颈癌晚期患者中显示出一定的效果。然而，治疗方案的选择应当根据具体癌症类型、病情和患者个体差异来制定。对于其他类型的癌症患者，是否适合采用这种化疗方案还需要进行更多研究和临床试验来确定。建议患者在选择化疗方案时，应与医生进行全面讨论，并结合个人情况做出决策。",
  "query": "这个研究对宫颈癌晚期患者使用异环醚胺和美斯那的效果进行了研究。你认为这种化疗方案是否适合其他类型的癌症患者？",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: 这个研究对宫颈癌晚期患者使用异环醚胺和美斯那的效果进行了研究。你认为这种化疗方案是否适合其他类型的癌症患者？\n\n<reference text>: Cancer Chemother Pharmacol 1986;18:280-283.Available at: http://www.ncbi.nlm.nih.gov/pubmed/3802384.258.Sutton GP, Blessing JA, McGuire WP, et al.Phase II trial of ifosfamide and mesna in patients with advanced or recurrent squamous carcinoma of the cervix who had never received chemotherapy: a Gynecologic Oncology Group study.\n\n<reply>: ",
  "response": "根据相关研究，异环醚胺和美斯那化疗方案在宫颈癌晚期患者中显示出一定的效果。然而，治疗方案的选择应当根据具体癌症类型、病情和患者个体差异来制定。对于其他类型的癌症患者，是否适合采用这种化疗方案还需要进行更多研究和临床试验来确定。建议患者在选择化疗方案时，应与医生进行全面讨论，并结合个人情况做出决策。"
}